NfL is released into the cerebrospinal fluid and peripheral blood following neuronal injury such as that caused by stroke (10), traumatic brain injury (11), amyotrophic lateral sclerosis (12), and other central nervous system diseases, thereby, it as a promising biomarker for neuronal damage (13, 14). The gene discussed is NEFL; the disease is Stroke.